60 chewable nano tablets per bottle
To show that B12 suppresses appetite in nondeficient adults we need human clinical trials that measure hunger, calorie intake, and weight changes in randomized, controlled settings
These pathways may involve both receptor-dependent and receptor-independent mechanisms related to metabolic regulation
But as you can see, these high supplement doses may be aggravating (skin-wise) for the average person who receives B12 from dietary sources, such as red meat, chicken, eggs and fish
Despite these promising findings, it is critical to evaluate safety, as there is a significant lack of comprehensive clinical trials to establish the safety or efficacy of BPC-157 in humans
These formulation variables drive topical GHK-Cu dosage decisions